Drug Profile
Fozivudine
Alternative Names: BM 211290; Fozivudine tidoxil; FZT; HDP 99.0002; HDP 990002; W 09726867Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Heidelberg Pharma
- Class Antivirals; Deoxyribonucleosides; Dideoxynucleosides; Lipids; Pyrimidine nucleosides
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 09 Oct 2017 Heidelberg Pharma is now called Heidelberg Pharma Research
- 18 May 2005 Fozivudine is available for licensing (http://www.heidelberg-pharma.com)
- 15 Jun 2004 Phase-II clinical trials in HIV infections treatment in Germany (PO)